late-life semaglutide treatment slows ageing and extends lifespan in female mice

late-life semaglutide treatment slows ageing and extends lifespan in female mice

Will Generic Semaglutide Beat Brand for Access?

Generic semaglutide will likely outpace the brand in access, with a projected 35% price reduction driving broader uptake. Health Canada’s approval opens a pathway for millions of Canadians waiting for an affordable GLP-1 option. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice.